Bradykinin increases the secretion and expression of endothelin-1 through kinin B2 receptors in melanoma cells

Peptides

Volumn 31, Issue 2, 2010, Pages 238-241

  Andoh, Tsugunobu ^a   Akira, Ahmad ^a   Saiki, Ikuo ^a   Kuraishi, Yasushi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Bradykinin; Endothelin 1; Kinin B2 receptor; Melanoma cell

Indexed keywords

BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR; ENDOTHELIN 1; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION; REGULATORY MECHANISM;

ANIMALS; BRADYKININ; CELL LINE, TUMOR; ENDOTHELIN-1; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; MELANOMA, EXPERIMENTAL; MICE; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2;

EID: 73949158706     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.12.003     Document Type: Article

References (29)

1. Abassi Z.A., Tate J.E., Golomb E., and Keiser H.R. Role of neutral endopeptidase in the metabolism of endothelin. Hypertension 20 (1992) 89-95
2. 4 in mice. J Invest Dermatol 123 (2004) 196-201
3. Bagnato A., and Rosanò L. The endothelin axis in cancer. Int J Biochem Cell Biol 40 (2008) 1443-1451
4. 2+. Biochem Pharmacol 49 (1995) 1785-1791
5. Bunn Jr. P.A., Chan D., Dienhart D.G., Tolley R., Tagawa M., and Jewett P.B. Neuropeptide signal transduction in lung cancer: clinical implications of bradykinin sensitivity and overall heterogeneity. Cancer Res 52 (1992) 24-31
6. Cella D., Petrylak D.P., Fishman M., Teigland C., Young J., and Mulani P. Role of quality of life in men with metastatic hormone-refractory prostate cancer: how does atrasentan influence quality of life?. Eur Urol 49 (2006) 781-789
7. 2 receptors to release conjointly endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells. Br J Pharmacol 96 (1989) 920-926
8. + channels are targets for bradykinin B1 receptor ligands and for lipopolysaccharide in the rat aorta. Eur J Pharmacol 525 (2005) 123-127
9. 2+, and ionic fluxes in PC12 cells treated with bradykinin. J Biol Chem 263 (1988) 17350-17359
10. A endothelin receptor in mechanical allodynia in mice given orthotopic melanoma inoculation. J Pharmacol Sci 106 (2008) 257-263
11. 2 receptors in skin cancer pain produced by orthotopic melanoma inoculation in mice. Eur J Pain, in press, PMID: 19932979.
12. Higashida H., Salmina A., Hashii M., Yokoyama S., Zhang J.S., Noda M., et al. Bradykinin activates ADP-ribosyl cyclase in neuroblastoma cells: intracellular concentration decrease in NAD and increase in cyclic ADP-ribose. FEBS Lett 580 (2006) 4857-4860
13. 2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth. Cancer Res 64 (2004) 5178-5185
14. Lee C.H., Shieh D.C., Tzeng C.Y., Chen C.P., Wang S.P., Chiu Y.C., et al. Bradykinin-induced IL-6 expression through bradykinin B2 receptor, phospholipase C, protein kinase Cδ and NF-κB pathway in human synovial fibroblasts. Mol Immunol 45 (2008) 3693-3702
15. Leeb-Lundberg L.M., Marceau F., Müller-Esterl W., Pettibone D.J., and Zuraw B.L. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57 (2005) 27-77
16. Masaki T. Historical review: endothelin. Trends Pharmacol Sci 25 (2004) 219-224
17. 2 bradykinin receptor. Proc Natl Acad Sci USA 88 (1991) 7724-7728
18. Moreau M.E., Garbacki N., Molinaro G., Brown N.J., Marceau F., and Adam A. The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci 99 (2005) 6-38
19. 1 receptor. Biochim Biophys Acta 1442 (1998) 177-185
20. Park J.Y., Kim Y.M., Song H.S., Park K.Y., Kim Y.M., Kim M.S., et al. Oleic acid induces endothelin-1 expression through activation of protein kinase C and NF-κB. Biochem Biophys Res Commun 303 (2003) 891-895
21. Raidoo D.M., Sawant S., Mahabeer R., and Bhoola K.D. Kinin receptors are expressed in human astrocytic tumour cells. Immunopharmacology 43 (1999) 255-263
22. 1 antagonists in a murine bone cancer pain model. J Pain 6 (2005) 771-775
23. Seyrantepe V., Hinek A., Peng J., Fedjaev M., Ernest S., Kadota Y., et al. Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1. Circulation 117 (2008) 1973-1981
24. Shichiri M., Hirata Y., Nakajima T., Ando K., Imai T., Yanagisawa M., et al. Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines. J Clin Invest 87 (1991) 1867-1871
25. Velazquez E.F., Yancovitz M., Pavlick A., Berman R., Shapiro R., Bogunovic D., et al. Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma. J Transl Med 5 (2007) 2
26. Wacnik P.W., Eikmeier L.J., Ruggles T.R., Ramnaraine M.L., Walcheck B.K., Beitz A.J., et al. Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J Neurosci 21 (2001) 9355-9366
27. Wu J., Akaike T., Hayashida K., Miyamoto Y., Nakagawa T., Miyakawa K., et al. Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues. Int J Cancer 98 (2002) 29-35
28. Wulfing P., Diallo R., Kersting C., Wulfing C., Poremba C., Rody A., et al. Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up. Clin Cancer Res 9 (2003) 4125-4131
29. Zhang H.W., Sasamura T., Iida Y., Nojima H., Murata J., Saiki I., et al. Algogenic effects of the extract of the tumor mass isolated from mice with orthotopic inoculation of melanoma cells. Pain Res 16 (2001) 43-49